Literature DB >> 18945940

Slow myosin heavy chain expression in the absence of muscle activity.

O Agbulut1, A Vignaud, C Hourde, E Mouisel, F Fougerousse, G S Butler-Browne, A Ferry.   

Abstract

Innervation has been generally accepted to be a major factor involved in both triggering and maintaining the expression of slow myosin heavy chain (MHC-1) in skeletal muscle. However, previous findings from our laboratory have suggested that, in the mouse, this is not always the case (30). Based on these results, we hypothesized that neurotomy would not markedly reduced the expression of MHC-1 protein in the mouse soleus muscles. In addition, other cellular, biochemical, and functional parameters were also studied in these denervated soleus muscles to complete our study. Our results show that denervation reduced neither the relative amount of MHC-1 protein, nor the percentage of muscle fibers expressing MHC-1 protein (P > 0.05). The fact that MHC-1 protein did not respond to muscle inactivity was confirmed in three different mouse strains (129/SV, C57BL/6, and CD1). In contrast, all of the other histological, biochemical, and functional muscle parameters were markedly altered by denervation. Cross-sectional area (CSA) of muscle fibers, maximal tetanic isometric force, maximal velocity of shortening, maximal power, and citrate synthase activity were all reduced in denervated muscles compared with innervated muscles (P < 0.05). Contraction and one-half relaxation times of the twitch were also increased by denervation (P < 0.05). Addition of tenotomy to denervation had no further effect on the relative expression of MHC-1 protein (P > 0.05), despite a greater reduction in CSA and citrate synthase activity (P < 0.05). In conclusion, a deficit in neural input leads to marked atrophy and reduction in performance in mouse soleus muscles. However, the maintenance of the relative expression of slow MHC protein is independent of neuromuscular activity in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945940     DOI: 10.1152/ajpcell.00408.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  16 in total

1.  Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy.

Authors:  Yusuke Sato; Hans Christian Probst; Ryuichi Tatsumi; Yoshihide Ikeuchi; Michael S Neuberger; Cristina Rada
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

2.  Mouse transgenic lines that selectively label Type I, Type IIA, and Types IIX+B skeletal muscle fibers.

Authors:  Joe V Chakkalakal; Shihuan Kuang; Mario Buffelli; Jeff W Lichtman; Joshua R Sanes
Journal:  Genesis       Date:  2012-01-06       Impact factor: 2.487

3.  Expression of nuclear-encoded genes involved in mitochondrial biogenesis and dynamics in experimentally denervated muscle.

Authors:  Akira Wagatsuma; Naoki Kotake; Kunihiko Mabuchi; Shigeru Yamada
Journal:  J Physiol Biochem       Date:  2011-03-11       Impact factor: 4.158

4.  Myocytic androgen receptor controls the strength but not the mass of limb muscles.

Authors:  Céline Chambon; Delphine Duteil; Alban Vignaud; Arnaud Ferry; Nadia Messaddeq; Rocco Malivindi; Shigeaki Kato; Pierre Chambon; Daniel Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

5.  Calcineurin plays a modulatory role in loading-induced regulation of type I myosin heavy chain gene expression in slow skeletal muscle.

Authors:  Clay E Pandorf; Weihua H Jiang; Anqi X Qin; Paul W Bodell; Kenneth M Baldwin; Fadia Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-05       Impact factor: 3.619

6.  Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy.

Authors:  Eva Andres-Mateos; Heinrich Brinkmeier; Tyesha N Burks; Rebeca Mejias; Daniel C Files; Martin Steinberger; Arshia Soleimani; Ruth Marx; Jessica L Simmers; Benjamin Lin; Erika Finanger Hedderick; Tom G Marr; Brian M Lin; Christophe Hourdé; Leslie A Leinwand; Dietmar Kuhl; Michael Föller; Silke Vogelsang; Ivan Hernandez-Diaz; Dana K Vaughan; Diego Alvarez de la Rosa; Florian Lang; Ronald D Cohn
Journal:  EMBO Mol Med       Date:  2012-11-19       Impact factor: 12.137

7.  Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle.

Authors:  Pierre Joanne; Christophe Hourdé; Julien Ochala; Yvain Caudéran; Fadia Medja; Alban Vignaud; Etienne Mouisel; Wahiba Hadj-Said; Ludovic Arandel; Luis Garcia; Aurélie Goyenvalle; Rémi Mounier; Daria Zibroba; Kei Sakamoto; Kei Sakamato; Gillian Butler-Browne; Onnik Agbulut; Arnaud Ferry
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

8.  Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis.

Authors:  Emanuele Rizzuto; Simona Pisu; Antonio Musarò; Zaccaria Del Prete
Journal:  Ann Biomed Eng       Date:  2015-01-29       Impact factor: 3.934

9.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.

Authors:  Valérie Risson; Laetitia Mazelin; Mila Roceri; Hervé Sanchez; Vincent Moncollin; Claudine Corneloup; Hélène Richard-Bulteau; Alban Vignaud; Dominique Baas; Aurélia Defour; Damien Freyssenet; Jean-François Tanti; Yannick Le-Marchand-Brustel; Bernard Ferrier; Agnès Conjard-Duplany; Klaas Romanino; Stéphanie Bauché; Daniel Hantaï; Matthias Mueller; Sara C Kozma; George Thomas; Markus A Rüegg; Arnaud Ferry; Mario Pende; Xavier Bigard; Nathalie Koulmann; Laurent Schaeffer; Yann-Gaël Gangloff
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

10.  Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.

Authors:  Aline Huguet; Fadia Medja; Annie Nicole; Alban Vignaud; Céline Guiraud-Dogan; Arnaud Ferry; Valérie Decostre; Jean-Yves Hogrel; Friedrich Metzger; Andreas Hoeflich; Martin Baraibar; Mário Gomes-Pereira; Jack Puymirat; Guillaume Bassez; Denis Furling; Arnold Munnich; Geneviève Gourdon
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.